Key Takeaways
- In 2022, globally, 39.9 million people were living with HIV, with women and girls accounting for 53% of adults aged 15+
- In sub-Saharan Africa, women aged 15-24 are three times more likely to acquire HIV than men of the same age
- In Eastern Europe and Central Asia, men represent 82% of new HIV diagnoses in 2022
- Globally, 1.3 million women became newly infected with HIV in 2022
- In sub-Saharan Africa, new HIV infections among young women aged 15-24 outnumbered those among young men by a factor of 4.2 in 2022
- In Asia and the Pacific, 41% of new HIV infections in 2022 were among women
- In 2023, 86% of people living with HIV knew their status, with women more likely to test at 92% vs 80% for men
- In sub-Saharan Africa, only 72% of women living with HIV know their status compared to 65% of men
- In the US, women are diagnosed later than men, with 17% vs 13% at stage 3 (AIDS)
- In 2022, 77% of people living with HIV were on ART, with 84% women vs 70% men globally
- In sub-Saharan Africa, 89% of women on ART vs 82% men
- In the US, 66% of women living with HIV are virally suppressed vs 64% men
- In 2022, 630,000 AIDS-related deaths, with women accounting for 43% globally
- In sub-Saharan Africa, women mortality rate from HIV is 1.2 times higher than men due to late diagnosis
- In the US, HIV mortality among women decreased 9% from 2020-2021
HIV affects men and women differently depending on where they live globally.
Mortality by Gender
- In 2022, 630,000 AIDS-related deaths, with women accounting for 43% globally
- In sub-Saharan Africa, women mortality rate from HIV is 1.2 times higher than men due to late diagnosis
- In the US, HIV mortality among women decreased 9% from 2020-2021
- Globally, men have higher HIV-related mortality (380,000 vs 250,000 women)
- In Eastern Europe, men account for 85% of AIDS deaths
- In India, 70% of HIV deaths are men
- In South Africa, women 55% of AIDS deaths despite higher prevalence
- In Brazil, mortality rate 4.5 per 100,000 men vs 2.8 women
- Globally, TB/HIV co-infection deaths 70% in men
- In Kenya, maternal HIV deaths 15% of total women mortality
- In Ukraine, 80% HIV deaths among men who inject drugs
- In Nigeria, AIDS mortality 60% men
- In Thailand, 75% deaths MSM and male sex workers
- In the UK, HIV deaths 75% men
- In Mozambique, women 48% of deaths
- Globally, survival after ART initiation 5 years 85% women vs 80% men
- In Zimbabwe, male mortality 1.5 times female post-diagnosis
- In Russia, excess mortality men 90%
- In Eswatini, equal gender distribution in recent deaths due to high treatment
Mortality by Gender Interpretation
New Infections by Gender
- Globally, 1.3 million women became newly infected with HIV in 2022
- In sub-Saharan Africa, new HIV infections among young women aged 15-24 outnumbered those among young men by a factor of 4.2 in 2022
- In Asia and the Pacific, 41% of new HIV infections in 2022 were among women
- In the US, men accounted for 80% of new HIV diagnoses in 2021, totaling 29,438 cases
- In Eastern Africa, adolescent girls represent 22% of all new adult HIV infections despite being only 10% of the population
- In Brazil, 65% of new HIV cases in 2022 were among men
- In Ukraine, men comprise 85% of new HIV diagnoses due to injecting drug use
- Globally, key populations including men who have sex with men account for 35% of new HIV infections
- In Kenya, women aged 15-24 have an HIV incidence rate 5.5 times higher than men of the same age
- In Russia, 90% of new HIV infections are among men, primarily through heterosexual transmission and drug use
- In 2022, 1.5 million people acquired HIV globally, with gender disparities varying by region
- In Nigeria, 70% of new infections among young people are in girls
- In Thailand, men who have sex with men represent 40% of new infections
- In Europe, 70% of new diagnoses are in men
- In Zimbabwe, young women have 3 times higher incidence than young men
- In the UK, 82% of new HIV diagnoses in 2022 were in men
- In Mozambique, girls aged 15-19 have twice the HIV prevalence of boys
- Globally, 160,000 children newly infected, mostly girls due to vertical transmission risks
- In Eswatini, women account for 62% of new infections
- In 2022, men who have sex with men had 28 times higher HIV incidence than general adult population
New Infections by Gender Interpretation
Prevalence by Gender
- In 2022, globally, 39.9 million people were living with HIV, with women and girls accounting for 53% of adults aged 15+
- In sub-Saharan Africa, women aged 15-24 are three times more likely to acquire HIV than men of the same age
- In Eastern Europe and Central Asia, men represent 82% of new HIV diagnoses in 2022
- Globally, adolescent girls and young women aged 15-24 account for 75% of new HIV infections among adolescents
- In Western and Central Africa, 64% of people living with HIV are women
- In South Asia, men account for 80% of people living with HIV
- In Latin America, transgender women have an HIV prevalence of 20-30% in some urban areas
- In the United States, Black women represent 39% of new HIV diagnoses among women in 2021
- In India, the HIV prevalence among men who have sex with men is 4.7%
- In South Africa, women comprise 61% of people living with HIV aged 15+
Prevalence by Gender Interpretation
Testing and Diagnosis by Gender
- In 2023, 86% of people living with HIV knew their status, with women more likely to test at 92% vs 80% for men
- In sub-Saharan Africa, only 72% of women living with HIV know their status compared to 65% of men
- In the US, women are diagnosed later than men, with 17% vs 13% at stage 3 (AIDS)
- Globally, pregnant women testing coverage reached 88% in 2022
- In Eastern Europe, men are 50% less likely to test for HIV than women
- In India, only 75% of men who have sex with men have ever tested for HIV
- In South Africa, 95% of antenatal clinic attendees are tested, but only 70% of men at primary care
- In Brazil, HIV testing among transgender women is 85%, higher than general population due to targeted programs
- Globally, men are 20% less likely to know their HIV status than women
- In Kenya, female sex workers have 90% testing coverage, while men lag at 65%
- In Ukraine, only 55% of men who inject drugs have tested in the past year
- In the EU/EEA, 91% of diagnosed women are linked to care vs 89% men
- In Nigeria, 80% of women know status vs 60% men
- In Thailand, MSM testing rates are 85%, higher than heterosexual men at 50%
- In the UK, Black African women test at higher rates than Black Caribbean men
- In Mozambique, partner testing for women is 45%, men 30%
- Globally, self-testing kits increased male testing by 15% in pilots
- In Zimbabwe, 92% of pregnant women tested vs 68% adult men
- In Russia, testing coverage among men is 50%, women 70%
- In Eswatini, 89% women know status vs 78% men
Testing and Diagnosis by Gender Interpretation
Treatment and ART by Gender
- In 2022, 77% of people living with HIV were on ART, with 84% women vs 70% men globally
- In sub-Saharan Africa, 89% of women on ART vs 82% men
- In the US, 66% of women living with HIV are virally suppressed vs 64% men
- Globally, treatment coverage for women is 85%, men 69%
- In Eastern Europe, only 60% of men on ART vs 75% women
- In India, 75% of women on ART retention at 12 months vs 70% men
- In South Africa, viral suppression 73% women, 65% men
- In Brazil, 90% linkage to care for women vs 85% men
- Globally, children under 15 have 65% ART coverage, girls slightly higher than boys
- In Kenya, 98% retention for pregnant women on ART
- In Ukraine, men retention on ART 55% vs 70% women
- In Nigeria, 82% women virally suppressed vs 70% men
- In Thailand, MSM ART coverage 88%, higher than general men
- In the UK, 97% diagnosed on ART, equal for genders
- In Mozambique, women 92% on ART vs 80% men
- Globally, DREAMS program increased ART initiation in AGYW by 25%
- In Zimbabwe, 85% women suppressed vs 75% men
- In Russia, ART coverage 50% men vs 65% women
- In Eswatini, 90% women on treatment vs 82% men
Treatment and ART by Gender Interpretation
Sources & References
- Reference 1UNAIDSunaids.orgVisit source
- Reference 2WHOwho.intVisit source
- Reference 3AIDSINFOaidsinfo.unaids.orgVisit source
- Reference 4CDCcdc.govVisit source
- Reference 5NACOnaco.gov.inVisit source
- Reference 6GOVgov.brVisit source
- Reference 7PHIAphia.icap.columbia.eduVisit source
- Reference 8ECDCecdc.europa.euVisit source
- Reference 9GOVgov.ukVisit source
- Reference 10NASCPnascp.gov.ngVisit source
- Reference 11THAIAIDSSOCIETYthaiaidssociety.orgVisit source
- Reference 12EUROeuro.who.intVisit source
- Reference 13NIHnih.org.zaVisit source
- Reference 14DATAdata.unicef.orgVisit source
- Reference 15NASCOPnascop.or.keVisit source
- Reference 16ALLIANCEalliance.org.uaVisit source
- Reference 17THAIGOVthaigov.go.thVisit source
- Reference 18BHIVAbhiva.orgVisit source
- Reference 19MISAUmisau.gov.mzVisit source
- Reference 20USAIDusaid.govVisit source
- Reference 21NACnac.org.zwVisit source
- Reference 22AIDSaids.ruVisit source
- Reference 23NERCHAnercha.org.szVisit source
- Reference 24SAMRCsamrc.ac.zaVisit source
- Reference 25AIDSaids.gov.thVisit source






